Health Care Deal News, January 26, 2015 - Top 5 Biotech Deals in January


Brought to you by


Week ending January 23, 2015: 


Recent Health Care M&A Deals


Target Price
Home Health & Hospice    

Madison Dearborn Partners

Walgreens Infusion Services. N/A
Extendicare Inc. Revera Home Health $83 million
Accelera Innovations, Inc. Accelera Innovations, Inc.
$6 million
Physician Medical Groups    

Radisphere Corporation




Health Care Staffing Services See M&A Uptick  

A lot of ink goes into stories about hospitals and health systems buying physician medical practices and the financial downside that can create. Another problem hospitals face is efficient staffing and scheduling. Investors are catching on. Last week, Envision Healthcare Holdings, Inc. (NYSE: EVHC) paid $123 million for Vista Staffing Solutions, part of On Assignment, Inc. (NYSE: ASGN). That deal follows the January 6 announcement that London-based Sovereign Capital Partners LLP acquired Nurse Plus, a staffing and homecare service with 35 branches across England. We’ll be looking into this area in more depth in a future issue of Health Care M&A News



Biotech Deals Take the Lead in January

Last year, health care M&A talk was all about pharmaceuticals, and with good reason. That sector accounted for 188 (14%) of the 1,300 deals, but $213 billion (55%) of the record $387.4 billion spent on health care deals. The Biotechnology sector posted 136 deals (10%), but only $21 billion (5% of the total). With only three weeks into 2015, however, biotech deals are burgeoning: 20 deals announced, with a total of $6.7 billion. Not bad, for January.


Top Five Biotechnology Transactions in Janaury 2015




Shire plc NPS Pharmaceuticals $5.2 billion
Roche Foundation Medicine $780 million
Biogen Idec Convergence Pharmaceuticals $200 million
Roche Trophos $139.2 million
Merck & Co. Moderna Therapeutics collaboraion $14.3 million

Source: The Health Care M&A Information Source, January 23, 2015



Welch Allyn Buys into Telemedicine with Hubble Telemedical Deal

The remote patient monitoring field is mushrooming in 2015, as mobile health startups and tele-medicine firms compete for investors’ attention. Last week, Hubble Telemedical, a privately held maker of remote diabetic retinopathy screening tools, was acquired for an undisclosed sum by Welch Allyn, Inc., maker of implements used in physical exams, as well as EMR-connected solutions that monitor vital signs and cardiac activity. The acquisition strengthens Welch Allyn’s presence in primary care settings, and adds to its other vision screening technologies.  Oh, and positions it well for telehealth consultations.

Investing in Outcomes Starts with Startups

Improving patient outcomes is the mantra of savvy healthcare services investors. And a couple of VC firms hope they’ve made a good choice by betting on Inflexxion, which develops behavioral change programs that reduce health-related risks, improve clinical outcomes, positively influence quality of care and improve public health. Last week the company announced financial investments, amount undisclosed, from Periscope Equity LLC, Fidus Investment Corporation and Akoya Capital Partners. Consilium Partners, a Boston-based investment bank, acted as the exclusive financial advisor to the company in connection with the transaction................Click here for a free trial to The Health Care M&A Information Source and download the current issue today.


Around the Web in Health Care M&A...Click here to see more

Webcast Calendar...Click here to see more


Upcoming Investor Conferences...Click here to see more


Previous Issues of Health Care Deal News...Click here to see more